L
Lani Prideaux
Researcher at St. Vincent's Health System
Publications - 35
Citations - 2121
Lani Prideaux is an academic researcher from St. Vincent's Health System. The author has contributed to research in topics: Crohn's disease & Inflammatory bowel disease. The author has an hindex of 17, co-authored 32 publications receiving 1852 citations. Previous affiliations of Lani Prideaux include University of Melbourne & Monash Medical Centre.
Papers
More filters
Journal ArticleDOI
Crohn's disease management after intestinal resection: a randomised trial
Peter De Cruz,Peter De Cruz,Michael A. Kamm,Michael A. Kamm,Amy L. Hamilton,Kathryn J. Ritchie,Efrosinia O. Krejany,Alexandra Gorelik,Danny Liew,Lani Prideaux,Ian C. Lawrance,Jane M. Andrews,Peter A. Bampton,Peter R. Gibson,Miles P. Sparrow,Rupert W. Leong,Timothy H. Florin,Richard B. Gearry,Graham L. Radford-Smith,Finlay A. Macrae,H.S. Debinski,Warwick Selby,Ian Kronborg,M. Johnston,Rodney Woods,P. Ross Elliott,Sally Bell,Steven J. Brown,William Connell,Paul V. Desmond +29 more
TL;DR: Treatment according to clinical risk of recurrence, with early colonoscopy and treatment step-up for recurrence), is better than conventional drug therapy alone for prevention of postoperative Crohn's disease recurrence.
Journal ArticleDOI
Inflammatory bowel disease in Asia: A systematic review
Lani Prideaux,Michael A. Kamm,Michael A. Kamm,Peter De Cruz,Francis K.L. Chan,Siew C. Ng,Siew C. Ng +6 more
TL;DR: In Asia, UC is more prevalent than CD, although CD incidence is rapidly increasing in certain areas, and there is a male predominance of CD in Asia, but a trend towards equal sex distribution for UC.
Journal ArticleDOI
Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery
Emily K Wright,Emily K Wright,Michael A. Kamm,Michael A. Kamm,Peter De Cruz,Peter De Cruz,Amy L. Hamilton,Amy L. Hamilton,Kathryn J. Ritchie,Efrosinia O. Krejany,Steven T. Leach,Alexandra Gorelik,Danny Liew,Lani Prideaux,Lani Prideaux,Ian C. Lawrance,Ian C. Lawrance,Jane M. Andrews,Jane M. Andrews,Peter A. Bampton,Peter A. Bampton,Simon Jakobovits,Timothy H. Florin,Peter R. Gibson,H.S. Debinski,Finlay A. Macrae,Finlay A. Macrae,Douglas Samuel,Ian Kronborg,Graham L. Radford-Smith,Warwick Selby,M. Johnston,Rodney Woods,P. Ross Elliott,Sally Bell,Steven J. Brown,William Connell,Andrew S. Day,Paul V. Desmond,Paul V. Desmond,Richard B. Gearry +40 more
TL;DR: In this analysis of data from a prospective clinical trial, FC measurement has sufficient sensitivity and NPV values to monitor for CD recurrence after intestinal resection and its predictive value might be used to identify patients most likely to relapse.
Journal ArticleDOI
Postoperative recurrent luminal Crohn's disease: a systematic review.
TL;DR: A number of clinical risk factors for the development of earlier postoperative recurrence have been identified, and reasonable evidence is now available regarding the efficacy of drug therapies in preventing recurrence.
Journal ArticleDOI
Serological antibodies in inflammatory bowel disease: A systematic review
Lani Prideaux,Lani Prideaux,Peter De Cruz,Peter De Cruz,Siew C. Ng,Siew C. Ng,Siew C. Ng,Michael A. Kamm,Michael A. Kamm +8 more
TL;DR: There is currently insufficient evidence to recommend the use of antibody testing to predict responses to treatment or surgery in patients with IBD, but the combined presence and magnitude of a large panel of antibodies appear to be of value in predicting disease progression.